The average P/S ratio for GILD's competitors is 5.92, providing a benchmark for relative valuation. Gilead Sciences Inc Corp (GILD) exhibits a P/S ratio of 4.54, which is -23.35% above the industry average. Given its robust revenue growth of 6.40%, this premium appears unsustainable.